Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Se Ik Kim

Showing results (131-140 of 138) with videos related to

Pageof 14
Sort By:
You have reached the last page of results.This site can display upto 138 results.
Gynecologic Oncology|May 3, 2021
Uterine serous carcinomaGiorgio Bogani, Isabelle Ray-Coquard, Nicole Concin, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|September 27, 2023
Gestational choriocarcinomaGiorgio Bogani, Isabelle Ray-Coquard, David Mutch, et al.
Gynecologic Oncology|January 22, 2022
Clear cell carcinoma of the endometriumGiorgio Bogani, Isabelle Ray-Coquard, Nicole Concin, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|July 31, 2025
Uterine leiomyosarcomaGiorgio Bogani, Giuseppe Caruso, Isabelle Ray-Coquard, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|December 30, 2022
Endometrial carcinosarcomaGiorgio Bogani, Isabelle Ray-Coquard, Nicole Concin, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|November 4, 2024
How to optimize and evaluate diversity in gynecologic cancer clinical trials: statements from the GCIG Barcelona MeetingJalid Sehouli, Jolijn Boer, Alison H Brand, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|April 14, 2025
How to optimize and evaluate diversity in gynecologic cancer clinical trials: statements from the GCIG Barcelona MeetingJalid Sehouli, Jolijn Boer, Alison H Brand, et al.
JAMA Oncology|June 25, 2026
Long-Term Outcomes in Patients With Recurrent Ovarian Cancer and Exceptional Response to PARP InhibitorsLucy Haggstrom, Yeh Chen Lee, Maria-Pilar Barretina-Ginesta, et al.
Pageof 14

Showing results (131-140 of 138) with videos related to

Sort By:
Pageof 14
You have reached the last page of results.This site can display upto 138 results.
Gynecologic Oncology|May 3, 2021
Uterine serous carcinomaGiorgio Bogani, Isabelle Ray-Coquard, Nicole Concin, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|September 27, 2023
Gestational choriocarcinomaGiorgio Bogani, Isabelle Ray-Coquard, David Mutch, et al.
Gynecologic Oncology|January 22, 2022
Clear cell carcinoma of the endometriumGiorgio Bogani, Isabelle Ray-Coquard, Nicole Concin, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|July 31, 2025
Uterine leiomyosarcomaGiorgio Bogani, Giuseppe Caruso, Isabelle Ray-Coquard, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|December 30, 2022
Endometrial carcinosarcomaGiorgio Bogani, Isabelle Ray-Coquard, Nicole Concin, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|November 4, 2024
How to optimize and evaluate diversity in gynecologic cancer clinical trials: statements from the GCIG Barcelona MeetingJalid Sehouli, Jolijn Boer, Alison H Brand, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|April 14, 2025
How to optimize and evaluate diversity in gynecologic cancer clinical trials: statements from the GCIG Barcelona MeetingJalid Sehouli, Jolijn Boer, Alison H Brand, et al.
JAMA Oncology|June 25, 2026
Long-Term Outcomes in Patients With Recurrent Ovarian Cancer and Exceptional Response to PARP InhibitorsLucy Haggstrom, Yeh Chen Lee, Maria-Pilar Barretina-Ginesta, et al.
Pageof 14